California officials are stepping up efforts to combat the spread of xylazine, a powerful animal sedative that’s increasingly being used by people, often with devastating results. It’s mostly been an East Coast phenomenon, but ‘tranq,’ as it is known, is beginning to appear in the Golden State.
State lawmakers have recently been debating whether and how to stiffen punishments for dealers, while Gov. Gavin Newsom is targeting fentanyl trafficking and distributing more naloxone. The problem, experts say, is one with no easy or clear answers.
Greene County, Tennessee, so far has received more than $2.7 million from regional and national settlements with opioid manufacturers and distributors. But most of the money is not going to help people and families harmed by addiction.
As marijuana has become far more mainstream, potent, and sometimes dangerous, uneven regulation at the state and federal levels leaves consumers at risk.
A few dozen high schools across the U.S. combine education with recovery treatment for substance use disorders to keep kids sober and in school.
A few dozen high schools across the U.S. combine education with recovery treatment for substance use disorders to keep kids sober and in school.
KHN gives readers a chance to comment on a recent batch of stories.
Doctors have no national standards on when to order urine tests to check whether adult ADHD patients are properly taking their prescription stimulants. Some patients are subjected to much more frequent testing than others.
The May 11 expiration of the federal government’s pandemic emergency declaration will affect patient care across a broad range of settings, including telemedicine, hospitals, and nursing homes.
The FDA has long blocked the importation of cheap medicine, agreeing with pharmaceutical manufacturers that it opens the door to opioids. The agency’s own data shows that rarely happens.
